☆ 4.7 Meeting Abstract

Efficacy and Safety of Tirzepatide, a Dual GIP/GLP-1 Receptor Agonist, Compared with Insulin Degludec in Patients with Type 2 Diabetes (SURPASS-3)

DIABETES (2021)

Get Full Text
Add to Collection

Journal

DIABETES
Volume 70, Issue -, Pages -

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/db21-78-LB

Keywords

-

Categories

Endocrinology & Metabolism

Funding

  1. Eli Lilly and Company

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.